Skip to main content
OpenTrials
Completed

NCT Number: NCT03772184

Modified Cervical Inversion During CS in Placenta Previa

There is an increasing rates of placenta previa nowadays

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Placenta Previa Female Urogenital Diseases and Pregnancy Complications Obstetric Labor Complications Placenta Diseases Pregnancy Complications Urogenital Diseases

Age range

22 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Algazeerah and helwan university

Giza, Egypt

About this study

several techniques were described to control bleeding .

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • pregnant women 38 weeks or more with placenta previa

Exclusion criteria

  • pregnant ladies with normally implanted placenta or placenta accreat , increta or percreta

Treatment and study plan

Cervical inversion

Procedure

inverting the cervical lip after delivery

Primary outcomes

  1. The number of women whose placental bed bleeding will be controlled by cervical inversion cervical inversion

    Time frame: within an hour

    how can the cervical inversion technique controls the placental bed bleeding

Sponsors and collaborators

Lead sponsor

Aljazeera Hospital

Other

Collaborators

  • Suez Canal University

Registry information

Official study title

Alalfy Modofied Cervical Inversion During CS in Placenta Previa

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Dec 11, 2018
Registry last updated
Feb 22, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.